4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-000597
President and Head of R&D acquired 324,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nagendran Sukumar · President and Head of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-02 | Grant or award : show line 1 in the form | +324,500 | 1,222,343 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-02 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +324,500 | 324,500 | D |
Loading xslF345X05/form4-01032025_100136.xml…